Dexcom on Tuesday announced that its new over-the-counter continuous glucose ... While Dexcom's existing G7 CGM system is available to this population, patients have to get a prescription for ...

In March 2024, the FDA approved the first over-the-counter continuous glucose ... Different Traditional prescription CGMs like the Dexcom G7 are designed for people with diabetes, offering tight ...

Dexcom launched the Stelo over-the-counter CGM and announced that the 15-day G7 system, cleared by the FDA, will be launched in the second half of 2025. The new system is expected to offer ...

The U.S. Food and Drug Administration has cleared the first over ... to a Dexcom news release. The company, based in San Diego, already has another monitor on the market, the Dexcom G7, for ...

DexCom recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose Monitoring System ...

Months after its G7 ... Dexcom is zeroing in on the U.S. market. The diabetes device maker originally submitted the G7 system to the FDA for review at the end of 2021 but hit a regulatory ...

carry-over and spillage. The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the ...

After collecting a long-awaited FDA clearance for the latest generation of its wearable continuous glucose monitor last December, Dexcom has offered a peek into the momentum behind its G7 diabetes ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...